Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy
Epilepsy affects 50 million people worldwide according to the World Health Organization and 20 –30% of patients develop resistance to antiepileptic drugs. The side effects of antiepileptic treatments represent a heavy economic burden (de Kinderen et al., 2014) and have a significantly negative impact on the quality of life (Luoni et al., 2011).
Source: Epilepsy Research - Category: Neurology Authors: Beatrice Mihaela Radu, Florin Bogdan Epureanu, Mihai Radu, Paolo Francesco Fabene, Giuseppe Bertini Tags: Review article Source Type: research